Home›Companies›Biotech & Pharma›Lento Bio

Lento Bio, Inc

Updated Oct 27, 2026·Latest SEC filing May 31, 2023·Suggest an edit

About Lento Bio

Lento Bio is a private company based in Lafayette, New York, incorporated in 2022 in Delaware. It has reported $0 raised in one offering on Form D since May 2023. Its chief executive is Kris Barnes.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetMay 31, 2023$0of $5.0M target0—EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lento Bio's Form D filed May 31, 2023.

KS
KM
Kelsey Moody
Director
KB
Kris Barnes
CEO and director

Sources

  1. SECLento Bio, Inc filing history